Graves Disease: all 162 studies
Page 2 of 2. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion AssessmentCompletedNCT03969108Phase 4
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- Liver Function After Intravenous Methylprednisolone AdministrationCompletedNCT03667157Phase 4
- Impact of Intravenous Methylprednisolone Treatment on Blood PressureCompletedNCT03590080
- Coagulation After Intravenous Methylprednisolone AdministrationCompletedNCT03535090
- Personalized Treatment in Thyroid DisordersSuspendedNCT03517579Not applicable
- Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' OrbitopathyCompletedNCT03498417
- The Oral Microbiota is Associated With Autoimmune ThyroiditisStatus unknownNCT03447093
- Intestinal Microbiota and Treatment of GDStatus unknownNCT03433352
- Gut Microbiota is Associated With Autoimmune Thyroid DiseaseStatus unknownNCT03390582
- Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt HyperthyroidismStatus unknownNCT03303053Phase 3
- Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves OrbitopathyCompletedNCT03278964Not applicable
- Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' OphthalmopathyStatus unknownNCT03066076Phase 3
- HIFU vs RAI in the Relapsed Graves' DiseaseCompletedNCT03013257Not applicable
- Clinical Application of Pulse Rate-monitoring Activity Trackers in ThyrotoxicosisCompletedNCT03009357
- K1-70 - A Study in Subjects With Graves' DiseaseCompletedNCT02904330Phase 1
- Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control StudyCompletedNCT02798965Not applicable
- Thiamine Supplement in Patients With Severe HyperthyroidismCompletedNCT02767245Not applicable
- Treatment of Graves' Hyperthyroidism With Selenium Plus MethimazoleCompletedNCT02727738Not applicable
- A Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' DiseaseCompletedNCT02685514Not applicable
- Thyroid Disease and Personality StudyStatus unknownNCT02620085
- DNA Methylation and Autoimmune Thyroid DiseasesCompletedNCT02491567
- D-vitamin And Graves' Disease; Morbidity And Relapse ReductionCompletedNCT02384668Not applicable
- Characteristics of Islet β-cell Functions in Chinese Patients With Graves' DiseaseCompletedNCT02376088
- Role of the Microbiome in Graves' OrbitopathyStatus unknownNCT02373995Phase 1/2
- B-cell Depletion Therapy With Rituximab for Thyroid Eye DiseaseTerminatedNCT02316691
- Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' DiseaseStatus unknownNCT02210741
- Doxycycline Treatment in Mild Thyroid-Associated OphthalmopathyStatus unknownNCT02203682Phase 2
- Thyroid Disorders in Malaysia: A Nationwide Multicentre StudyCompletedNCT02190214
- Comparative Study of Different I-131 Doses in Graves' DiseaseStatus unknownNCT02114619Not applicable
- Shared Decision Making in Graves Disease - Graves Disease (GD) ChoiceCompletedNCT02107794Not applicable
- Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)CompletedNCT02059655Phase 4
- The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.WithdrawnNCT01927406Phase 4
- Post-Radioiodine Graves' Management: The PRAGMA-StudyCompletedNCT01885533
- Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' OrbitopathyCompletedNCT01727973Phase 1/2
- Bupivacaine Injection of Eye Muscles to Treat StrabismusStatus unknownNCT01616108Phase 2/3
- Selenium Supplementation Versus Placebo in Patients with Graves' HyperthyroidismCompletedNCT01611896Not applicable
- Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's PatientsCompletedNCT01560299Not applicable
- Function of Regulatory T Cells Improved by Dexamethasone in Graves' PatientsCompletedNCT01534169Phase 1
- Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)CompletedNCT01458600Phase 4
- Subtotal Versus Total Thyroidectomy for Graves' DiseaseCompletedNCT01408368Not applicable
- Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External ThyroidectomyTerminatedNCT01320813Not applicable
- Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and ToleranceCompletedNCT01295333Phase 3
- Differential Diagnosis of STA-PSV in ThyrotoxicosisCompletedNCT01227499
- Application of Digital Infrared Thermal Imaging (DITI) in Graves' DiseaseStatus unknownNCT01182584
- Comparison of Different Doses of 131I in Severe Graves' HyperthyroidismCompletedNCT01039818Phase 3
- Autoimmune Thyroid Disease Genetic StudyCompletedNCT00958113
- Prevention Relapse of Graves' Disease by Intrathyroid Injection of DexamethasoneCompletedNCT00917241Phase 4
- Remission Induction and Sustenance in Graves' Disease 2CompletedNCT00796913Not applicable
- Predictive Genetic Risk Assessment TrialCompletedNCT00782366
- Color Doppler Imaging of Orbital Venous Flow in Grave's OrbitopathyCompletedNCT00697528
- Low Doses of Cholestyramine in the Treatment of HyperthyroidismCompletedNCT00677469Not applicable
- Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves' DiseaseCompletedNCT00505011
- Effect of Lugol's Solution in the Patients With Graves' DiseaseCompletedNCT00432146
- Rituximab Treatment of Graves' Dysthyroid OphthalmopathyCompletedNCT00424151Phase 1/2
- Is the Routine Pressure Dressing After Thyroidectomy Necessary?CompletedNCT00400465Phase 4
- TSH Receptor Antibody Heterogeneity in Children and Adolescents With Graves' DiseaseCompletedNCT00335062
- Antithyroid Drugs During Radioiodine TherapyCompletedNCT00150137Phase 4
- Block-replacement Therapy During Radioiodine TherapyCompletedNCT00150124Phase 4
- Rituximab in the Treatment of Graves' DiseaseCompletedNCT00150111Phase 1/2
- rhTSH, Thyroid Size, and Radioiodine Therapy in Benign GoiterCompletedNCT00145366Phase 2
- Randomized Study of Sequential Orbital Radiotherapy for Graves' OphthalmopathyCompletedNCT00004660Not applicable